Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes

International Journal of Molecular Sciences(2020)10.3390/ijms21093323Source: DataRank Database

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes is a research paper published in International Journal of Molecular Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.34)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Christopher R. Cogle ORCID,Leylah Drusbosky ORCID

Live enrichment

PubMed:32397113 PMC:PMC7246771 OpenAlex:https://openalex.org/W3021234977

National Institutes of Health

Grant: UL1TR001427

Leukemia and Lymphoma Society

Grant: 2400-13

Celgene

Grant: P0091329

National Institutes of Health

Grant: 5UL1TR001427-08

Together: Transforming and Translating Discovery to Improve Health

FWCI

0.34

Citation Percentile

0.6%

Citation Trend

2021

2022

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/21/9/3323/pdf?version=1588929373

publisherhttps://www.mdpi.com/1422-0067/21/9/3323/pdf?version=1588929373

publisherhttps://www.mdpi.com/1422-0067/21/9/3323/pdf

journalhttps://doi.org/10.3390/ijms21093323

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32397113

Fields of Study

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchMultiple Myeloma Research and Treatments03 medical and health sciences0302 clinical medicine

MeSH Terms

RNA Splicing FactorsLenalidomideChromosome DeletionComputer SimulationDNA-Binding ProteinsDrug ResistanceHumansMyelodysplastic SyndromesPhosphoproteinsProto-Oncogene ProteinsDioxygenasesPresenilin-2Biomarkers, PharmacologicalHigh-Throughput Nucleotide SequencingKaryotypeWnt3A ProteinMyeloid Cell Leukemia Sequence 1 Protein

Keywords

LenalidomideMyelodysplastic syndromesTrisomyOncologyBiologyInternal medicineMedicineGeneticsMultiple myelomaBone marrowResistanceComputational ModelingRefractory DiseaseCommunicationKaryotypeDrug ResistanceHigh-Throughput Nucleotide SequencingPhosphoproteinsBiomarkers, PharmacologicalDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsWnt3A ProteinPresenilin-2HumansMyeloid Cell Leukemia Sequence 1 ProteinComputer SimulationRNA Splicing FactorsChromosome Deletion

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being